Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate plus depot medroxyprogesterone acetate every 8 weeks in Asian men
ISRCTN31330564Phase 2Terminated
- Sponsor
- United Nations Development Programme
- Start
- Jun 2003
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01
Overview
Phase 2, open-label trial of testosterone undecanoate and medroxyprogesterone acetate in male contraception (2 arms), sponsored by United Nations Development Programme. Primary endpoints: Change in sperm concentration to azoospermia or severe oligozoospermia and Time to suppress spermatogenesis. Started Jun 2003; status: terminated.
02
Drugs
testosterone undecanoatemedroxyprogesterone acetate
03
Conditions
male contraception
Beyond the preview
Go deeper on ISRCTN31330564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN31330564.